Clinical trials recruiting for HER2-positive Advanced Breast Cancer
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Indiana | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| New York | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Washington | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
- Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
Related conditions
Trials recruiting for HER2-positive Advanced Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HER2-positive Advanced Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.